X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 20/Mar 12:25

ARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat Estimates

ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of 1,400% and 273.26%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

2nd Regional Energy Transition Outlook for Africa Advisory Meeting

irena.org - 14/Apr 14:00

The 2nd Regional Energy Transition Outlook for Africa Advisory Meeting will focus on a discussion of the preliminary analysis.